ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Sertraline can alleviate neuronal and synaptic damage in the hippocampus of PTSD mice and inhibit the increase in myelin.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Posttraumatic stress disorder (PTSD) is a complex psychiatric disorder, and previous studies have suggested that its pathogenesis is related to hippocampal dysfunction. Sertraline, a commonly used medication for treating PTSD, has an unclear mechanism of action. In this study, we assessed the behavioral performance of PTSD mice through the open field test, Y-maze, and forced swimming test. We also examined changes in hippocampal neurons, synapses, and myelin sheaths in PTSD mice using hematoxylin-eosin staining, Nissl staining, Luxol fast blue staining, and transmission electron microscopy. Furthermore, in order to simulate clinical conditions, we administered sertraline treatment to the PTSD group of mice. The results showed that sertraline significantly improved anxiety, despair, and learning and memory in PTSD mice. Histological analysis revealed that sertraline inhibited neuronal damage, restored synaptic function, and reduced excessive myelin sheath proliferation. In conclusion, the findings of this study may provide a basis for the future use of sertraline in the treatment of PTSD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.